Category: Drug Discovery
Global Drug Discovery
-
Global Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 GLP-1 receptor agonists are a type of non-insulin medication used to treat type 2 diabetes in conjunction with diet and exercise. These medications are used to help lower blood glucose ... Read More
-
Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2023-2029
... of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc. LPI (LP Information)' newest research report, the “Follicular Lymphoma Drugs Industry Forecast” ... Read More
-
Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits
... patients, although it is considered to be clinically less severe. Monkeypox has recently emerged as a prominent orthopox virus affecting public health. In May 2022, multiple cases of the disease were reported in several non-endemic ... Read More
-
2023 Global: Alzheimer'S Disease Drug - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
2023 Global: Amyotrophic Lateral Sclerosis (Als) Treatment - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Alzheimer's Disease- Drug Pipeline Landscape, 2023
... gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ... Read More
-
2023 Global: Artificial Intelligence (Ai) In Drug Discovery - Innovative Markets Forecast (2029) report
... and regional data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Global Acne Therapeutics Market - 2023-2030
... CAGR of 4.7% during the forecast period (2023-2030). Adolescence is the most common time for acne, an inflammatory condition of the pilosebaceous units. Open (black) and closed (white) comedones, inflammatory papules, pustules, nodules, and cysts ... Read More
-
Global Dermatology Drug Market Growth (Status and Outlook) 2023-2029
... newest research report, the “Dermatology Drug Industry Forecast” looks at past sales and reviews total world Dermatology Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Dermatology Drug sales ... Read More
-
Global Microbiome Therapeutics Market Growth (Status and Outlook) 2023-2029
... eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of ... Read More
-
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2023-2029
... Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically ... Read More
-
Global Eosinophilic Esophagitis Drug Market Growth 2023-2029
... cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant ... Read More
-
Cystic Fibrosis Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Company Analysis
... ongoing genetic disease that affects the lungs and other body systems (Pancreas, Liver, and Kidney) and for which there is currently no cure. It mainly affects the digestive and respiratory systems in children and young ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... Renub Research. Chronic inflammatory lung disease causes breathing difficulties. It is a group of progressive lung diseases. The most common diseases are emphysema and chronic bronchitis. COPD, if left untreated, can lead to worsening respiratory ... Read More
-
Global Urinary Tract Infecion Therapeutics Market Research Report 2022-2032
... forecast period 2022-32. According to a recently published report by Fatpos Global on “Urinary Tract Infecion Therapeutics Market” delivers a detailed overview of the market in terms of market segmentation by material type, by thickness, ... Read More
-
Healthcare Bioconvergence Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery, Regenerative Medicine, Nanorobotics for Drug Delivery, Bioelectronics, Engineered Living Materials, Optogenetics, Precision Medicine, and Diagnostic and Biological Sensor); By Region; Segment Forecast, 2023 - 2032
... 2023 - 2032 The global healthcare bioconvergence market size is expected to reach USD 249.24 billion by 2032, according to a new study by Polaris Market Research. The report “Healthcare Bioconvergence Market Share, Size, Trends, ... Read More
-
Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... is a growing brain disorder that, with time, destroys retention and reasoning skills daily. As of know we do not know any reason for the cause Alzheimer disease. Instead, the disease is caused by genetic, ... Read More
-
Acute Respiratory Distress Syndrome Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Syndrome (ARDS) is a hazardous illness in which the lungs are highly swollen. The disease is related to capillary endothelial injury and diffuse alveolar damage. ARDS commonly spread within 24 to 48 hours of the ... Read More
-
Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... (AMD) is an eye ailment that may worsen over time. It is the prime cause of severe, permanent vision loss in people over 60. It occurs when the small central portion of the retina, called ... Read More
-
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Drugs In Development, 2022, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) ... Read More
-
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tinea Pedis (Athlete Foot) - Drugs In Development, 2022, provides an overview of the Tinea Pedis (Athlete Foot) (Infectious Disease) pipeline ... Read More
-
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Drugs In Development, 2022, provides an overview ... Read More
-
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Drugs In Development, 2022, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease that results from infection with the Toxoplasma ... Read More
-
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections - Drugs In Development, 2022, provides an overview of the Zika Virus Infections (Infectious Disease) pipeline landscape. Zika virus infection ... Read More
-
Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever - Drugs In Development, 2022, provides an overview of the Dengue Fever (Infectious Disease) pipeline landscape. Dengue is a mosquito borne infectious disease ... Read More
Research Assistance
